To investigate the potential association of plasma Chromogranin and candidate SNPs in the Chromogranin gene with early-onset MI in an Indian population.
Not Applicable
- Conditions
- Health Condition 1: - Health Condition 2: null- Confirmed MI subjects, â?¤ 40 years old
- Registration Number
- CTRI/2018/05/013566
- Lead Sponsor
- Dr Ajit Mullasari
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Confirmed MI subjects, <= 40 years old
Exclusion Criteria
Cancer or Hepatitis positive or HIV positive
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To minimize the effects <br/ ><br>of aging-related confounding factors on the <br/ ><br>disease association and increase the chance <br/ ><br>of detecting pathogenetic role for CHGA in MI. <br/ ><br>Timepoint: To minimize the effects <br/ ><br>of aging-related confounding factors on the <br/ ><br>disease association and increase the chance <br/ ><br>of detecting pathogenetic role for CHGA in MI. <br/ ><br>
- Secondary Outcome Measures
Name Time Method To minimize the effects <br/ ><br>of aging-related confounding factors on the <br/ ><br>disease association and increase the chance <br/ ><br>of detecting pathogenetic role for CHGA in MI. <br/ ><br>To detect whether <br/ ><br>plasma CHGA level and certain CHGA SNPs <br/ ><br>or haplotypes are associated with early-onset <br/ ><br>MI. <br/ ><br>Timepoint: To minimize the effects <br/ ><br>of aging-related confounding factors on the <br/ ><br>disease association and increase the chance <br/ ><br>of detecting pathogenetic role for CHGA in MI. <br/ ><br>To detect whether <br/ ><br>plasma CHGA level and certain CHGA SNPs <br/ ><br>or haplotypes are associated with early-onset <br/ ><br>MI. <br/ ><br>